Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome

Ref ID 635
First Author A. C. Ford
Journal AMERICAN JOURNAL OF GASTROENTEROLOGY
Year Of Publishing 2010
URL https://pubmed.ncbi.nlm.nih.gov/19920807/
Keywords • Pharmacological
• Missing data
• Error
• Cochrane
Problem(s) • Weaknesses identified in some Cochrane reviews
• Errors in study inclusion or omission of relevant studies
• Data extraction errors and double counting
Article Type Empirical
Article Subtype Meta-epidemiological analysis
First Author Country United States
Aim To identify and replicate all published systematic reviews and meta-analyses that examined pharmacological interventions for IBS.
Level of Investigation Analytical
Summary of Findings In fi ve of the eight meta-analyses 13 – 29 % of included trials were ineligible according to investigators ’ criteria, constituting 8 – 26 % of included patients. Six of the meta-analyses missed 17 separate published eligible trials; 3 – 11 % of eligible patients were, as a result, not included. All eight meta-analyses contained errors in dichotomous data extraction, in 29 – 100 % of truly eligible trials, leading to errors in 15 of 16 reported pooled treatment effects.
Number of systematic reviews included 8
Number of eligible systematic reviews assessed 120